Miglustat (N-Butyldeoxynojirimycin) hydrochloride is an orally active and reversible ceramide glucosyltransferase inhibitor. Miglustat hydrochloride can be used for the research of type I gaucher disease[1][2].
Molecular Weight:
255.74
Purity:
98
CAS Number:
[210110-90-0]
Formula:
C10H22ClNO4
Target:
Glucosylceramide Synthase (GCS)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted